Kairos Pharma (NYSEAMERICAN:KAPA) Earns Buy Rating from Analysts at HC Wainwright
HC Wainwright began coverage on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a report released on Thursday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $12.00 target price on the stock. Several other equities research analysts have also recently weighed in on the company. Maxim Group started coverage on […]
HC Wainwright began coverage on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a report released on Thursday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $12.00 target price on the stock. Several other equities research analysts have also recently weighed in on the company. Maxim Group started coverage on […]
